Metastatic Locally Advanced Merkel Cell Carcinoma

DrugDrug NameDrug Description
DB15766RetifanlimabA PD-1–blocking antibody indicated for the treatment of adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma.
DrugDrug NamePhaseStatusCount